KRYS Jan 2025 130.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

11.20

0.00

(0.00%)

As of 11:34AM EDT. Market open.

Loading interactive chart…

Zacks
Earnings Estimates Moving Higher for Krystal Biotech (KRYS): Time to Buy?
Krystal Biotech (KRYS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks
Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why
Krystal Biotech (KRYS) soars 36.5% on strong uptake of its newly approved drug Vyjuvek and encouraging pipeline progress.
Simply Wall St.
3 High Insider Ownership US Stocks With Up To 55% Revenue Growth
Amidst a robust week for U.S. stocks, fueled by significant advancements in AI and cloud computing from major technology firms, the market landscape appears increasingly conducive to exploring growth opportunities. In this context, companies with high insider ownership can be particularly compelling, as they often signal strong confidence from those who know the business best.